scPharmaceuticals (SCPH) 10 Aug 232023 Q2 Earnings call transcript

Good day and welcome to the scPharmaceuticals Second Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to PJ Kelleher of LifeSci Advisors. Please go ahead.

operator. you, Thank

forward call limited make the business and statements FUROSCIX. management, would future laws, and facts, I this of results the Before federal financial statements the following over for regarding remarks plans and to securities are historical than the call, but All expectations statements concerning like the within conference meaning not turning including other to looking to forward-looking management’s on expected statements. scPharmaceuticals,

these XX-K, your in statements, call, this update Any is by as forward-looking statements except on made based law. including the your expressed condition expect, and from questions implied guidance, responses statements. operating include, and the limited is may to the guarantees which are by as annual These uncertainties confidence, to, estimate, by statements. SEC statements forward-looking and and on to other believe, similar not other expressions today but other company attention Form and quarterly scPharmaceuticals on forward-looking conference typically or performance, project involve not anticipate, risks used what expressly other subject scPharmaceuticals factors reports contained to intent obligation Form to Actual may that in to identify and qualifications words The financial and differ and may report with but outcomes are or required intend, other are results of of future materially are These risk factors results. expectations target, certain current disclaims any reports and are forward-looking these business, directed. such important affect filed scPharmaceuticals forward-looking XX-Q

my call Executive Mr. to pleasure Tucker, John? scPharmaceuticals. over It Chief to the now is Officer of John turn

Commercial our operational our for to a call President, Parsons, listening Chief and Financial our to over Thank of update detailed on for to an Steve This a launch provide am afternoon’s the and everyone call PJ Officer and thanks Noakes, Senior before webcast. financials. Rachael update turning afternoon, FUROSCIX to I this Vice pleased you, more review the then

questions. will the We open for call then your

The physicians late our from hospital the while to first still reflect trend. a is indicators continue heart are costly quarter gaining admissions And availability field full the it force represents avoiding patients. being in positive and prescribing early launched to unique system by product failure as written commercial underlying of comfort it readmissions received quarter treating thereby market and sales that we the February. the benefit prescribers, second is of well including XXXX in-services can who demand, FUROSCIX total prescriptions our inconvenient completed in their key are it and quickly patients to and FUROSCIX to

this at $X.X revenue of to the million, reported quarter, of our For weeks we approximately net pharmacy the at second weeks normalizing partners end specialty of the from QX the X QX. start XX inventory despite at

main have was our pharmacy orders early QX. already month best to-date in placed In specialty two addition, our and July partners launched sales

these treating XX%, from to and at detailed We previously. guided well discount of anticipate that the heart evaluate ensure to launch as contracting and running through QX, GTM do of terms In net their force in update our in will that it failure we positive over to to will trends, which XX% our sales commercial the shortly. a is broadly field provide is with continue But approximately evolves. physicians. that to patients guidance we payers gross accessible continue demand Steve time end long-term FUROSCIX response to below territories is increase

the XX territories an second current quarter. positive anticipate sales the This these brings force impact add To additional to seeing of end, beginning XX field this the quarter. our and of we towards sales that end additions we territories

In addition, quarter. and of recruiting next territories latest physicians are we FUROSCIX, in tranche based contributions seeing to identified actively QX. the for We the anticipate these we of end seen by we this the have from have fill interest on these positions

with and FUROSCIX, we securing payers, to initial continue now FUROSCIX to on effort that involves formulary have patients, This possible. continuing to tier in a Medicaid have most also Shifting productive payers, and the Part working most to favorable Medicare commercial, terms discussions be make not available to tier. broadly a it the D specialty only but patients coverage placed affordable not of on will at to

placed effective health Part June this its status for formulary D preferred beneficiaries. recall its goal the progress, We X. all securing plan with continued that five our formulary remain of top plan regarding favorable across similarly placement plans on Reflecting of in with Medicare its FUROSCIX plans national commercial discussions

coverage In XXXX. addition, national we FUROSCIX obtained Medicaid July X, of effective

are in of the engaged we more that or to indicated FUROSCIX co-pays and previously we come. with time. many more access and $XXX of tier heart XX% fixed like announcements these or all mentioned, approximately reiterating to As over are of months failure plans can goal we several less have XX% under other patients We health hope our

are We goal. good making progress this towards

the stage, four heart annually. heart The can the this again, the of we opportunity a we wide X.X FUROSCIX, failure estimated million if And million to GX aggressive heart are we physicians in potential total adults XX FUROSCIX Of from and than million failure, early of billion. X.X suffering U.S. believe other significant we from believe interventions patients others. effectively failure the prescription alone, from per are access it the resulting FUROSCIX U.S per require X include suffering and is as to alone, is million seeing is there market doses worth a which discretion of FUROSCIX. some range have $X,XXX episodes assume we be In at to countries. for be reiterating. addressed of this At by doses is X treating the $X this opportunity those, we of episode, nearly is market If adults XX.X events there a are in is that more

continue X.X number doses over will prescription we per to quarter, second per X we this But doses prescription. just over towards trend time. that the reported believe During

the opportunity Staying market for topic moment. a of on

It all recently, regarding X estimated these we Class of failure heart Type benefit Class Class the potential X is XX% failure we as positive Just feedback to of as the for many from XX% estimated X Class FUROSCIX FUROSCIX. Association as meeting indicated. and which from may is in FUROSCIX as are heart patients expansion considered many that to currently that New of addition received Heart FDA indication the X and C include York patients

so based Class if market the of we to to are represent FUROSCIX expansion received we successful, we any failure X who So do plan without be heart prescribed the to meaningful of need our that additional patients. able And we can opportunity the from the we sickest file feedback believe upon for agency the year. studies, without end Class the the indication when by X

I of the enables formulations IP, cover estate. the We to to with possibility dosing want covering to flexibility of subcutaneous more a of the U.S. of respect development key recently patents furosemide. concentrated our key issuance development This now Turning announced of furosemide. intellectual property

the properties. formulations studies described We multiple in have initial completed on patent solubility stability

We and IND-enabling potential product candidates identified we initiated have studies. have

patients We furosemide entirely heart in with also of chronic congestions for covers in failure for for opportunity the also patients treatment company. have kidney significant patent indication our represents potential formulations also applications pending, disease, similar that a new edema with and that an market

pursuing are foundational also Taken States. FUROSCIX lifecycle similar management patent strategy is together, this we our of United the to additional protections outside IP

integrated provide an Cardinal plans systems. Before directly will turning the specialty to be several call We our moving update direct pharmacies. to and want agreements I FUROSCIX shipped performance purchase from on over indicators anticipate with key three our our facilities to these bypassing Steve, signing IDN XPL Health forward. health our

shipped are As counts, our of a result, captured longer the will be demand. in not which prescription those direct all will units reflect no underlying that

forward. the are to that going intend We KPIs reassessing provide we

We in report update we further quarter our when will results third a have November.

reflection Russell continuum. pleased progress this tireless made work XX added we a on heart unmet that have from very resulted were raise entire care of of XXXX we widely June behalf have addresses been which our help index the the in along Inclusion past months, followed we is FUROSCIX Index. visibility and that key Finally, announce company the will to to significant the that need failure the team. over There of the in

into turn launch our I Vice At Steve dive Steve? this will for Senior Commercial, our of Parsons the call deeper a point, metrics. over to President

John. Thank you,

John indicated, start and I our availability we commercial quarter was with the progress. to with As our of full pleased will on FUROSCIX team. first our continue commercial be update second an quarter

emerge. to territories ready stand we that demand previously FUROSCIX said to have patterns as for continue additional add We

force As our of note to field added we were territories John to XX that territories indicated, during to toward we the second important as of quarter, the territories. QX XX end bring the towards today meaningfully the and added It been is end fully trained offices and reps doctor’s heart in the such hospitals, QX as services failure at will conducting the contribute have are not until added quarter of additional and sales clinics. when face-to-face total

territories. As identified have earlier, John we additional mentioned

in We the in for quarter. those anticipate from fourth recruiting these the positions. of are beginning additional process territories We contributions

readiness. that training Demo in-services Our for compared XX. sales and is March June of provided of with In-services as at X,XXX provide providers force kits to to as instructions train conducted ensure are the XXX designed in-service. to each of FUROSCIX office completion XX has healthcare patients prescribing

through crucial use is and XXX continue to up launch From FUROSCIX. Our had prescribers, The XX. in-service June through be unique March ensuring which to is focus XXX encouraging. XX, we the results effective on on training from

Of were For total additional ended we XXX X,XXX pending. revenue. and filled had prescriptions June XX, the those, quarter were second XXX prescriptions

approved still process were waiting another a prescriber patient. contact that portion of the For the the still we on direction prescriptions with when there the is queued portion that are the and in that at were from to end payers for pending QX, and

the to filled continue into pending category We prescriptions with each move day.

prescriptions other cancelled And unreachable, too the high. For reasons been was to have being hospitalized, cases, patient some the FUROSCIX. deceased from prior receiving ranging vary, copay or the or patient that in

the Looking the out on written prescriptions ahead, that of filled better access pocket patients positioned anticipate lower more expense. for and will plan between prescriptions FUROSCIX and patients difference as is we providing formularies, narrow quicker health would

our prescriptions expectation. running quarter, than is second the of was which per the higher average X.XX, doses During number

the believe prescription be continue four to We doses number long-term. to right per

to terms Cardinal of our pleased as electronic Health with In provider continue and But of we Cardinal collateral, strategic with provider. logistics and many key and party key is activities third of Thus far process. that of our activities. and our some leaders, This through of appearances, encompasses are functioning are and different the although be partnership distribution a websites of we still working well broad adoption, we Biometrics. the engagement partners, continued pharmacy, our From with ongoing our among critical a and three the brand perspective, development marketing drive other have are pleased market including program specialty print tasks. we main awareness do, engaged on. development awareness, to campaign distribution multi-channel with pharmacy trajectory in we opinion Overall, the commitment. patient to both conference include progress lot work specialty the

That Rachael I Officer, Financial the a like would turn Rachel? Chief update, over concludes to now my call financial Nokes update. for to our

an pharmaceutical Selling, million were medical expenses administrative second XXXX. and the research Thank general period the you, of of for primarily quarter quarter compared $X.X of affairs in expenses costs, study XXXX, during cost for in legal and comparable commercial the net million. clinical quarter gross primarily was development and The second of costs, decrease $XX.X and related to development costs. quarter were the a expenses the $X.X XXXX. the product to and service development costs. for revenue general generated and to was to Steve. profit second administrative $X.X increase for $X.X million in in quarter employee increase million, of the of due professional expenses We costs yielding related was the in a Research compared million costs, second $X.X employee XXXX, revenue million $X.X XXXX. of and Decrease million quarter for for and And selling, due

period loss a net reported comparable million the quarter second XXXX. for of compared in million to a We net of of $XX.X the loss XXXX, $X.X for

of XX, million to June held we million compared as in XXXX. of equivalents XX, and investments, $XXX.X As XXXX, $XXX.X short-term December cash

was of outstanding shares June XX,XXX,XXX. scPharmaceuticals XXXX, As total XX,

That John? concludes update, the financial

for call This our this concludes Rachel. prepared questions. the we At remarks. point, Thanks, open will

Thank question with from you. Please ahead. comes first Jefferies. [Operator Instructions] go Our Santangelo Glen

June, of around which Thanks looking prepared John, numbers, at we’re sorry, was remarks Yes. took said of it the script, that I But something and in question. July. and early a for we your to details best your like in with step follow-up remarks, June May. sort step sort maybe of month wanted I modest reconciling my you last yes, of you said Hey, communication, if from I’m from taking sort think June and were modest July the Because sort in total looks down – prepared the on in just was filled where written yet. down took QX your a

helpful? the kind And of so that or we of trended And still matter give more a month maybe month? a if be month about how but things I’m anything to should just if any it’s reading be volatility, little can really curious too you into bit from commentary to sort us month early color

it’s launches had April to to over you XX%. it’s Sure. May, remember John. up still again, to huge Yes. from Glen, a early, from run And are May unpredictable, we lumpy. know, June, Thanks Yes,

we did quarter. filled May, in in see end come at lot saw higher were of at of A scripts month, a of demand we July. those So And of that the end the June. the then in the lot

filled June in just lot our last so over is but them up start good week remarks, been lot were my a as a up we’re of to – scripts And in in of July But QX. ended month, getting off said July. May in was best in And a was the July came our I June demand has of quite June bit a queued. actually scripts in getting

are relatively can And about maybe doesn’t out unique your talk that the done? that process you’re if right? way. expecting obviously written thought call by that sort should to X,XXX pretty across time, done it as of maybe we XXX you’re think or you in at But piece scripts unique provider. – and I scripts two should That’s you’re that. in-servicing now where a or mean, much I are I where broad look in number know work third seeing about be initiatives prescribers, prescribers follow-up you that like territories in quarter? pretty the it we per be what a more you with plan education this adding I but of the was to about we how mean, physician

add I’ll again, correct absolutely Glen, comment Steve, are this Hey, new virgin over you’re those territories, let John, territories. me is turn first, when we

to in-services beginning. like need the just do we So at

absolutely So the second, we’ve but make moving this their to as call you’re to part continue what just vital important going And third to see and in-services to doing. forward, and the learned, practice. the of second, the in-services are are we’re

doctors, products month it the had six mean, into it or X five there are results, takes and doing a going months ago, they their practice, lot times, did routine. in I a great, great those to used the reminding will patient, as calls. have offices, I’m into sure using for So, practitioner – that have docs keep just might me, be doing patients the we’re expanding two that, yes, results, adopted in, it’s interesting, writing. nurse going we really, the last a things, of thanks great of working got that, but that and or And the writers that we it just on said number forgot have great. that had and because the we have walk really still to but making their into lot their writers, a does prescribers practice unique mean, just time getting written, I getting I and have of one

to to add expand territories, services, practice. base, continue you anything writer goal make So to in they’re do that make there, we as is to and also want but the in that? back in continue sure into service, add their and re adopting getting maybe sure Steve, we’re that continuously them to again, our reminding do

well. it captures No, that

asked We count to Glen, one have If we when these unique will a one second providers, at the number. another do continue same If it do to then satellite a if We do the in reach going back that. to new they we don’t accounts, more territories, see it open basics, the in-service. even go way. if to we’re you location, our are count all to do we we us to fundamentals the won’t the But and in-services. locations, go or to existing location, proper

they’ll at we to always of a the were we doing clip part launch, So in-services, be be our not but nearly execution. will always that

Okay, thanks for the comments.

Glen. Thanks,

ahead. with comes go next Please Ruiz Partners. question Our Roanna from Leerink

And questions. [indiscernible] for would Thanks what your one like, Hi, are this good this curious, our sort Ruiz. think from just taking And a could for expect channel you contribution overall what you approximate to for agreements. have This sort these gross mentioned you evolve prepared How I from on impact in Roanna purchase net afternoon, over look remarks, everyone. forward? do agreements? direct Maybe time? what demand guess, your quick I of I’m this of is going right John, now? the seeing on

and own right? there, IDN. For let try and it, But the value hospitalization bottom about they of net, offer avoiding I’ll putting Nick. If the always the the IDN is you proposition me it the the is thought discount kind that on where start, lot on gross to depends the think flows it. strongest, line. and patient, those FUROSCIX We on we them to

where the But part on feel algorithm. treatment with quarter, the the write that’s doctors And IDNs. IDNs now. of always there the confident going our the really focus. affiliated having part IDNs, this we’re of to we’ve of that a key the scripts we pharmacies it’s happen thought really We’ve So directly had guideline the up IDNs hospitals end – that what IDNs, shipped if the are within working these product will within structure agreements to are

we’d we’ve business. So to say impact always that and this it’s hard thought have what the

don’t to internally. think work. a number in extra got It’s to coming There’s work line, it’s It write. These purchasing, business maybe at complicated in office not I cardiology pharmacy. So very people things little detailing longer. having into to we a starting of IDN of forecast them on to – like cardiologists and but what top it’s walking a are you

in hopefully they’ll think and And so they’re we’ve but think quarter. they this online come coming doing be obviously, that not We will been work. sales we it’s – now, online, our

I GTN, XX% up. We online, going have our think, rebating it’s part will the think have these don’t as the On will. to we to stay disciplined on we going we but of go These strategy. GTN it said, be still are that come

discipline. We have stayed

Sometimes it’s where co-pays, a giving showing little rebates. But think product. seeing the painful we’re not we’re of long-term when we because high the plan works, you’re gigantic those value the

it utilization and that We’re through showing their and then plans getting in the going the dispensing they PA it and they’re costs and are these not money, rebates.

from disciplined ones, So the under maximum the that thinking talking what rebates in in do are we rebate, the will stay major we IDN. our would be. where they’ll come that think like to with I we were

feel So and GTN the we impact really it’ll won’t contribute

John. question Helpful. inventory. then And on Thanks, maybe, quick

am you are those year, XXXX? quarter. end out to five I down of the mentioned expect of think how weeks by play I towards you the dynamics you to inventory just end the wondering the

Yes.

around normalized kind weeks. launch, week-to-week. think as five so to unpredictable it’s to going it Yes, day-to-day, we here. Nick. have are thanks of We Anytime stay just said, from So, I down we

it Eventually them. But contact of So, But little a to right of a now. inventory got them. week five-week end little of order with But year in they stays. a that normalizes We will like the probably to another sitting two-week maybe year. down it’s down any time And a hard, up year that’s of with the the we launch, or inventory. by a more locations. probably be to do through it’s can we to minimum tend I kind next stay where have end maybe keep the obviously the different number two or early weeks requirements, works think three-week. with the in at get lot But early that they to think they or

Helpful. queue. John. I will hop back Thanks in the

Thanks.

TD comes question Please from ahead. Cowen. go Stacy with Next Ku

quarter. for our congrats so questions Thanks taking much on and the

So, we few. have a

failure RTAC. First, have feedback these very specialists the heart clinician in been positive from

you FUROSCIX? so And Thanks So, trials, maybe question. maybe practices in that are the in weren’t that’s where just much you what of of adoption community first for So, involved follow-up of clinical details. So, some the metrics the for seeing settings? some of from on in boarder the more terms terms then the or are provided? patterns we awareness

you Would last, those or you able your any we year-end? would expected feedback are terms number of expectation provide in be you Given in the – willing about kind [Technical much. that to clinicians? Difficulty]? for see prescriptions, helpful any are to talk seeing improvements those fulfillment adopting maybe other within rate payer if guidance going you some are by what coverage, to anecdotal of willing average there. And be to provide are Thanks Maybe the so then of

I Stacy, Hey say couple then turn those of to over and a will Steve.

big on fulfillment only we – payer didn’t Xst. have rate, the had commercial So, June on the we

is at to came not reflected rate, fulfillment rate So, that’s fulfillment in which continue online I July all. X, and think Medicaid this the impact

spoke So, things XXth. race. so If to still doctors will we to, form, to or in as online. start since to think June move It’s as we have two of times a We the fulfillment have tick seen payers the or Steve three are up continue we back forward it’s as times the And fulfillment come delayed. couple go right. do also they him in we rate

we hospitalized being up lose patients. those and Now, some of the patients end

fulfillment will down. the co-pays go the in really with in dictated how both payers, by be rate things getting So,

that, well time. about fill a as talked have as improving We lot

that do to doctors’ is got hospitalized. the rates heart to work But we where So, continues need offices And continue. little we what us, script. they as know them sure plan we up education could the want at with bit the seen failure end Steve, the lag have talk make think continue payers the ticking and have being up and we to about for you that online, a will going to also that our with specialists? the fill start engagement with patient docs, exactly to come and fulfillment don’t to that doctors

Yes.

So, most of Those you with They people it. of are the adopters you in were that we timeframe. part utilization. part early weren’t the as engaging early the any March now as of trials described weren’t

Now, it’s regular docs. and some extra for It’s people who are with dealing with and much too this asking help. badly, problem of fluid patients feeling

so And broadened. the is adoption

in academic We are places.

in We are private practices.

in X,XXX are doctors and about average there of so It’s far. And They June. only prescriptions. number across who to But some do in have unique prescriber, done are really There started multiple at is prescribers. by divided that hard have say later you that one others prescriptions done communities. think look simple and board. math We per asked the can I you the

can the think as And So, all characterize within to I to, funnel or sometimes an like across they prescribers. it many then averages you board. it’s don’t everybody one office,

what answer to how question. But sure really not that’s So, are seeing. that precisely we

you. Thank Alright.

Thanks Stacy.

Our next with Wainwright. go Doug Please H.C. comes ahead. from question Tsao

afternoon. my taking questions. Hi, for Thanks good

being what’s to is you curious, when right currently John, Just, written script the it’s average when are now I experiencing time fulfillment am from that shipped? a

very a take This Steve, Yes. am the evading, am I it’s difficult closer I day-to-day to thing. I reports. is that. not And will

on and put very covered, back then want be get We who prescriptions out the the go form say Then we prescriptions want have a review place. in the have know eventually It’s answer. and is in they filled. doctors in expedited that the away, you They that be, there we do over quickly. to pretty XX-hour some note day. mark think off, really right co-pay to other advance, it And we they a to that heard out you appropriately come to write an all submit old, queue. want it those that what’s get same doctors going gets is going I have submit, and are

variability of to that a, it So, use average all offices because like wouldn’t and really the have an the to product. do want how the justice,

than last looking right. I scripts you from median mean if like better on Steve as week, said, are think probably felt is a Well, at this. we March doc Because a

you Tuesday. up it’s a you that going of median, the on at queued days were are is two payer we doc probably depends got Friday, on a again, trouble. it’s and there look later. go Just kind said, But right. and them two to doc send from about – the and information if it not and month or till patient could it probably probably obviously, the in ship either requiring days, at looking it’s And But a for of half median. the lot a is But or queued it Monday

So at it’s, we are looking it.

We have scripts that Steve said go out day. the same

get That’s well. cleared again, that written that big And it MSAs. morning, get and approve in afternoon. that as the plan pharmacy has be quickly, to and within does have but it and the specialty service, MSA a those to scripts has We courier an go happens

or Other what’s, because it’s can’t So, it’s when looking we to really at board. all kind at and it. hard look cute read if It’s we the see not, that. of than really over how

we had a we wish I that’s more answer, precise So, are. but where

of product, I will can’t you sort Tuesday. given it mean or out nature basis. And I seven script an sort am of to be I is the Friday, going the provide curious And Monday ultimately, week on until being – it’s that what of probably sort said to written are you the of be go not think scripts if coverage? a requested on like, expedited to are able a day written being a proportion of that

you do to…? want Steve,

Yes.

the patient we have if program a what’s a program. have we mean I have So, over weekend, really the the called QuickStart doctor needs

Whether them first we approved payer things that ship processed that time, it something prior second next time been go gets off, quickly the weekend. Saturday one a but patient, needs the dose, it enough really that product that do them really and any are is on through day a we day, will So, We that, potential or they you the usually ship there there to and for time not, one And It’s have has them the it’s can doctor we is any who get it, using after morning. program. a need quickly through It’s because them. only delay. QuickStart it it. gets

And well, as those samples for the patients. docs have

for So, doctor, cover that QuickStart between we covered have gap. an that the sample the and expedited

Thank so Great. Okay. you much.

Thanks Doug.

comes from Please Naz ahead. question Maxim go with next Rahman Our Group.

I Congrats just on far. had few C positive everyone. Type meeting. so the Hi, progress your a regarding questions

you this three? of patient on percentage give larger do you in could what’s applicable also patients, patients? all, a many patients? the about patients kind three us you of why of difference do between of four how four that and like class for let’s four for think finally, have two you class class us currently First only think doses what think And XX% class is FUROSCIX is the color those compared will those more And say, in and of the class need to those

not estimate of for qualified – try of am that had to going of John to that really, that’s think kind question. answer XX%, the market how many the on on them some we are share, I I it. what our So, But just

and we majority them going in have as edema to FUROSCIX of we pulmonary will in a need acute treatment form. know go to But hospital. them large of Some appropriate be to are the think

will four. on, that think do twos be probably governed or are John, do need it’s is then limits, quality say, those we the we doses. think that’s as the would care, script the higher than a let’s will they of with utilization far managed you by But a to patients, FDA? meeting later. bit a probably get would you another limits give But But quality if or for probably let’s two got more they script that want weeks threes. say As to per on next little for month the are bit the right, week light dosing,

sure. Yes,

class tolerate. the Association And four, exertion all of less upon exercise So, in four, difference one tolerated. the big the Heart between of you as which York amount through is really to the based New to of a with patient becomes classifications amount way degrees exercise certain go can

was the for expand York This when so discussion basis despite have able of Heart specific measure it’s that four. to way it be why in the So, this into which the and the with you when that in clinical they we done. trials, our three forth and patients with about agreed a clinical would we included that. clinical class back get Association to as into really have subjective is about really how two practice, mainly FDA classification, But trials, class New that problem great becomes you you

based to But expected As all it’s between the subcutaneous to answer with... the IV person directly, question to the agency. tolerate and which we and population. argument different be not pharmacokinetics the was is exercise amongst can much upon made That how your data the that to a

a expect like this Got you something six-month sNDA this, it. last on the is year review some, one Thanks. for you X Is or the And for, this? expecting are question regards to would cycle filing? the in is I guess review filing, this

expect would X a year We not review.

different couple trivializing all. do, there long device, that. Probably not a in think any avenues we to some at how of way that just months, but it’s the here. I Again, shorten data documentation, is there am think six the to a pretty clinical device putting takes might It’s be straightforward are really and review. we of I a not

XX-month think wouldn’t a, review a that. we So, it’s anything or like like full

taking Thanks Got it. for my questions.

Thanks Naz.

this at time. further questions are There no

like session. any would John to remarks. our back concludes closing Tucker, turn conference I this to for So, question-and-answer over the

failure That you evening. nice patients away who progress both continue today. And take anticipate in heart affordable to during on to as update execute a plan, the which to you continued you. providing prescriptions Thank and concludes for look We our have third very great hope are into we revenue. this call we a of We access forward growth believe more will translate our pleased our and our that information this quarter commercial November. Thank we in from have we with afternoon. call trajectory FUROSCIX, percentage

has presentation. attending for The concluded. you Thank now conference today’s

now may You disconnect.